ASTROTECH Corp Preferred Stock Dividends, Income Statement Impact
ASTROTECH Corp (ASTC) reported Preferred Stock Dividends, Income Statement Impact of $0 for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsIncomeStatementImpact · last filed 2015-05-11
- ASTROTECH Corp preferred stock dividends, income statement impact for the quarter ending 2015-03-31 was $0.00.
- ASTROTECH Corp preferred stock dividends, income statement impact for the quarter ending 2014-12-31 was $0.00.
- ASTROTECH Corp preferred stock dividends, income statement impact for the quarter ending 2014-09-30 was $531.00K.
- ASTROTECH Corp preferred stock dividends, income statement impact for the quarter ending 2014-03-31 was $0.00.
| Period end | Preferred Stock Dividends, Income Statement Impact 3 month | Preferred Stock Dividends, Income Statement Impact 6 month | Preferred Stock Dividends, Income Statement Impact 9 month |
|---|---|---|---|
| 2015-03-31 | $0.00 10-Q · filed 2015-05-11 | $0.00 derived: sum of 2 quarters · filed 2015-05-11 | $531.00K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-17 | $531.00K 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $531.00K 10-Q · filed 2014-11-14 | ||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-11 | $0.00 10-Q · filed 2015-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |